3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
44
Medulloblastoma
9
Lymphoma
9
Sarcoma
8
Brain Neoplasms
8
Neuroectodermal Tumors, Primitive, Peripheral
7
Central Nervous System Neoplasms
7
Rhabdomyosarcoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Wilms Tumor
5
Sarcoma, Ewing
5
Leukemia
5
Ganglioneuroblastoma
5
Burkitt Lymphoma
5
Astrocytoma
5
Rhabdoid Tumor
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hepatoblastoma
4
Glioma
4
Dendritic Cell Sarcoma, Interdigitating
4
Testicular Neoplasms
3
Retinoblastoma
3
Recurrence
3
Interventions
Patient Discharge
1
Melphalan
1
Magnetic Resonance Imaging
1
Infusions, Intra-Arterial
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Spinal Diseases
×
Melphalan
×
CNS
×
Clear all
NCT01637766
2020-08-03
SIAC
Weill Medical College of Cornell University
Phase 1
Completed
12 enrolled